Briana P Patton1, Elizabeth E Krans2,3, Joo Yeon Kim4,5, Marian Jarlenski4,5. 1. School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA. 2. Department of Obstetrics, Gynecology and Reproductive Sciences, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA. 3. Magee-Womens Research Institute, Pittsburgh, Pennsylvania, USA. 4. Department of Health Policy and Management, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania, USA. 5. Health Policy Institute, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Abstract
Background: Opioid use disorder (OUD) during pregnancy has increased dramatically over the past decade, as have associated adverse maternal health outcomes. Although Medicaid has long been the largest payer for deliveries in the United States, states' decisions to expand Medicaid eligibility to low-income adults has the potential to increase access to care for women in the postpartum period. This study aimed to determine the impact of the 2015 Pennsylvania Medicaid expansion on postpartum insurance coverage and preventive care utilization among pregnant women with opioid use disorder (OUD). Methods: In 2017, we conducted a retrospective cohort study using 2013-2015 administrative Medicaid data provided by the Pennsylvania Department of Human Services. We identified 1562 women with opioid use disorder who had a live birth delivery in a pre-Medicaid expansion or post-expansion study period. We compared length of continuous enrollment in Medicaid following delivery, postpartum visit attendance, and contraception initiation between groups. Results: More women in the post-expansion group remained enrolled in Medicaid at 300 days postpartum, relative to the pre-expansion group (87% vs. 81%). Medicaid expansion was not associated with differences in postpartum visit attendance or contraceptive use. However, women who remained enrolled in Medicaid for at least 300 days post delivery had an increased odds of postpartum visit attendance (odds ratio [OR]: 1.6, 95% confidence interval [CI]: 1.04, 2.4). Conclusion: The rate of continuous Medicaid enrollment among postpartum women with OUD was significantly higher after expansion, whereas rates of preventive care utilization were unaffected. Although improving insurance coverage for women with OUD is an important step to improve access to recommended preventive care, additional efforts are needed to ensure utilization of such care.
Background: Opioid use disorder (OUD) during pregnancy has increased dramatically over the past decade, as have associated adverse maternal health outcomes. Although Medicaid has long been the largest payer for deliveries in the United States, states' decisions to expand Medicaid eligibility to low-income adults has the potential to increase access to care for women in the postpartum period. This study aimed to determine the impact of the 2015 Pennsylvania Medicaid expansion on postpartum insurance coverage and preventive care utilization among pregnant women with opioid use disorder (OUD). Methods: In 2017, we conducted a retrospective cohort study using 2013-2015 administrative Medicaid data provided by the Pennsylvania Department of Human Services. We identified 1562 women with opioid use disorder who had a live birth delivery in a pre-Medicaid expansion or post-expansion study period. We compared length of continuous enrollment in Medicaid following delivery, postpartum visit attendance, and contraception initiation between groups. Results: More women in the post-expansion group remained enrolled in Medicaid at 300 days postpartum, relative to the pre-expansion group (87% vs. 81%). Medicaid expansion was not associated with differences in postpartum visit attendance or contraceptive use. However, women who remained enrolled in Medicaid for at least 300 days post delivery had an increased odds of postpartum visit attendance (odds ratio [OR]: 1.6, 95% confidence interval [CI]: 1.04, 2.4). Conclusion: The rate of continuous Medicaid enrollment among postpartum women with OUD was significantly higher after expansion, whereas rates of preventive care utilization were unaffected. Although improving insurance coverage for women with OUD is an important step to improve access to recommended preventive care, additional efforts are needed to ensure utilization of such care.
Authors: Torri D Metz; Polina Rovner; M Camille Hoffman; Amanda A Allshouse; Krista M Beckwith; Ingrid A Binswanger Journal: Obstet Gynecol Date: 2016-12 Impact factor: 7.661
Authors: Michelle Tuten; Sarah H Heil; Kevin E O'Grady; Heather Fitzsimons; Margaret S Chisolm; Hendrée E Jones Journal: Am J Drug Alcohol Abuse Date: 2009 Impact factor: 3.829
Authors: Wendy L Bennett; Hsien-Yen Chang; David M Levine; Lin Wang; Donna Neale; Erika F Werner; Jeanne M Clark Journal: J Gen Intern Med Date: 2014-01-29 Impact factor: 5.128
Authors: Yitong Alice Gao; Coleman Drake; Elizabeth E Krans; Qingwen Chen; Marian P Jarlenski Journal: J Addict Med Date: 2022-03-03 Impact factor: 4.647
Authors: Elizabeth Peacock-Chambers; Mary T Paterno; Daniel Kiely; Tinamarie Fioroni; Nancy Byatt; Peter D Friedmann Journal: Subst Abus Date: 2021-04-02 Impact factor: 3.716